Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.919 Q1 | 70 | 20 | 19 | 4722 | 108 | 19 | 6.67 | 236.10 | |
2 | Reviews in Contemporary Pharmacotherapy | journal | 0.471 Q2 | 18 | 1 | 27 | 209 | 34 | 27 | 0.60 | 209.00 | |
3 | Natural Product Reports | journal | 2.710 Q1 | 211 | 43 | 115 | 6706 | 741 | 113 | 6.77 | 155.95 | |
4 | Critical Reviews in Toxicology | journal | 1.068 Q1 | 129 | 20 | 64 | 2954 | 239 | 64 | 2.54 | 147.70 | |
5 | Progress in Medicinal Chemistry | journal | 0.872 Q1 | 38 | 8 | 25 | 1155 | 61 | 16 | 2.42 | 144.38 | |
6 | Studies in Natural Products Chemistry | book series | 0.332 Q3 | 49 | 37 | 146 | 5044 | 91 | 98 | 0.47 | 136.32 | |
7 | Progress in Drug Research | book series | 0.776 Q1 | 46 | 25 | 48 | 3042 | 120 | 43 | 1.97 | 121.68 | |
8 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.693 Q1 | 99 | 18 | 23 | 2152 | 137 | 22 | 3.43 | 119.56 | |
9 | Current Drug Targets: Inflammation and Allergy | journal | 0.161 Q3 | 53 | 27 | 26 | 2956 | 7 | 26 | 0.27 | 109.48 | |
10 | Current Drug Metabolism | journal | 1.339 Q1 | 122 | 38 | 87 | 4033 | 382 | 82 | 4.28 | 106.13 | |
11 | Current Pharmaceutical Biotechnology | journal | 0.723 Q1 | 97 | 39 | 78 | 4027 | 190 | 74 | 2.33 | 103.26 | |
12 | Expert Opinion on Therapeutic Targets | journal | 0.556 Q2 | 106 | 61 | 145 | 6058 | 209 | 142 | 1.67 | 99.31 | |
13 | Advanced Drug Delivery Reviews | journal | 1.934 Q1 | 366 | 101 | 376 | 9929 | 2293 | 334 | 6.61 | 98.31 | |
14 | Clinical Pharmacokinetics | journal | 1.316 Q1 | 184 | 82 | 236 | 7970 | 1235 | 228 | 4.62 | 97.20 | |
15 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
16 | Cellular and Molecular Life Sciences | journal | 3.001 Q1 | 261 | 236 | 561 | 20896 | 3039 | 545 | 5.26 | 88.54 | |
17 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 619 | 0 | 0 | 0.00 | 88.43 | ||
18 | American Journal of Respiratory Medicine | journal | 0.140 Q4 | 34 | 42 | 51 | 3646 | 14 | 45 | 0.27 | 86.81 | |
19 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
20 | Toxicological Reviews | journal | 49 | 23 | 0 | 1905 | 0 | 0 | 0.00 | 82.83 | ||
21 | Expert Opinion on Biological Therapy | journal | 0.869 Q1 | 102 | 116 | 176 | 9049 | 509 | 167 | 2.89 | 78.01 | |
22 | Handbook of Analytical Separations | book series | 0.185 Q3 | 13 | 15 | 55 | 1162 | 23 | 47 | 0.17 | 77.47 | |
23 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.138 Q3 | 8 | 17 | 49 | 1231 | 15 | 47 | 0.00 | 72.41 | |
24 | Expert Review of Vaccines | journal | 0.190 Q3 | 105 | 78 | 57 | 5374 | 27 | 53 | 0.47 | 68.90 | |
25 | Molecular Diagnosis and Therapy | journal | 68 | 57 | 172 | 3899 | 289 | 159 | 1.82 | 68.40 | ||
26 | Expert Opinion on Pharmacotherapy | journal | 0.541 Q2 | 93 | 204 | 417 | 13857 | 824 | 403 | 1.90 | 67.93 | |
27 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 154 | 3514 | 3 | 154 | 0.02 | 67.58 | |
28 | Drugs of Today | journal | 0.211 Q3 | 57 | 90 | 298 | 6018 | 178 | 296 | 0.75 | 66.87 | |
29 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | |
30 | Apoptosis : an international journal on programmed cell death | journal | 2.224 Q1 | 128 | 67 | 167 | 4199 | 760 | 165 | 4.73 | 62.67 | |
31 | Receptors and Channels | journal | 0.887 Q1 | 44 | 40 | 71 | 2478 | 131 | 67 | 2.00 | 61.95 | |
32 | Expert Opinion on Therapeutic Patents | journal | 0.453 Q2 | 88 | 125 | 408 | 7681 | 547 | 404 | 1.44 | 61.45 | |
33 | BioDrugs | journal | 0.499 Q2 | 79 | 55 | 198 | 3338 | 362 | 187 | 2.74 | 60.69 | |
34 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.100 Q4 | 5 | 10 | 39 | 590 | 0 | 39 | 0.00 | 59.00 | |
35 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.131 Q4 | 5 | 8 | 27 | 464 | 3 | 27 | 0.13 | 58.00 | |
36 | Current Opinion in Investigational Drugs | journal | 0.579 Q2 | 83 | 178 | 271 | 9705 | 545 | 254 | 2.01 | 54.52 | |
37 | Current Opinion in Drug Discovery and Development | journal | 0.700 Q2 | 85 | 94 | 252 | 4970 | 556 | 238 | 2.34 | 52.87 | |
38 | Neuropsychopharmacology | journal | 2.486 Q1 | 249 | 274 | 538 | 14161 | 3018 | 505 | 5.11 | 51.68 | |
39 | Environmental Toxicology and Pharmacology | journal | 0.395 Q3 | 106 | 38 | 136 | 1943 | 160 | 131 | 1.20 | 51.13 | |
40 | Drugs of the Future | journal | 0.435 Q2 | 46 | 93 | 256 | 4750 | 329 | 256 | 1.30 | 51.08 | |
41 | Journal of Molecular Medicine | journal | 1.600 Q1 | 157 | 98 | 321 | 4851 | 1147 | 289 | 3.41 | 49.50 | |
42 | Psychopharmacology | journal | 1.743 Q1 | 214 | 325 | 973 | 15797 | 3718 | 929 | 3.64 | 48.61 | |
43 | Journal of Drug Evaluation | journal | 5 | 21 | 0 | 1019 | 0 | 0 | 0.00 | 48.52 | ||
44 | Current Opinion in Pharmacology | journal | 1.606 Q1 | 148 | 108 | 199 | 5208 | 819 | 182 | 4.12 | 48.22 | |
45 | Toxin Reviews | journal | 0.227 Q3 | 54 | 43 | 47 | 2070 | 41 | 41 | 0.77 | 48.14 | |
46 | Antiviral Research | journal | 0.995 Q1 | 151 | 95 | 230 | 4546 | 757 | 230 | 3.36 | 47.85 | |
47 | Drug News and Perspectives | journal | 0.181 Q3 | 53 | 85 | 190 | 4052 | 72 | 190 | 0.38 | 47.67 | |
48 | Cardiovascular Drugs and Therapy | journal | 0.559 Q2 | 79 | 57 | 235 | 2692 | 302 | 196 | 1.23 | 47.23 | |
49 | Fundamental and Clinical Pharmacology | journal | 0.367 Q3 | 85 | 76 | 171 | 3587 | 207 | 166 | 1.17 | 47.20 | |
50 | Neuropharmacology | journal | 1.830 Q1 | 191 | 219 | 760 | 10316 | 3065 | 760 | 3.83 | 47.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®